Improvements in CT technology and the appropriate use of CT contrast materials enable a more
accurate evaluation of cancer stage both at the beginning of the diagnostic process and during the
treatment course. In this podcast, Prof. Eisenblätter illustrates the advantages of adopting one of
the most reliable sets of criteria for measuring tumor response, the RECIST criteria, and provides
some precious tips for correct radiologic reporting.